Skip to main navigation Skip to search Skip to main content

Dissemination of Escherichia coli producing AmpC-type β-lactamase (CMY-11) in Korea

  • Jae Young Kim
  • , Jae Seok Song
  • , Song Hee Bak
  • , Young Eun Cho
  • , Dae Wi Kim
  • , Seok Hoon Jeong
  • , Yeong Min Park
  • , Kye Joon Lee
  • , Sang Hee Lee*
  • *Corresponding author for this work
  • U1 University
  • Seoul National University
  • Myongji University
  • Kosin University
  • Pusan National University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Among the 51 clinical isolates collected from a university hospital in Korea, nine isolates were resistant to cephamycins. Nine isolates were shown to produce CMY-11 and these also included three isolates producing TEM-1. The results from ERIC-PCR revealed that dissemination of CMY-11 was due to outbreaks of resistant species and to the intra-species spread of resistance to cephamycins in Korea. CMY-11 β-lactamase genes from nine clinical isolates that were responsible for resistance to cephamycins (cefoxitin and cefotetan), amoxicillin, cephalothin and amoxicillin-clavulanic acid, were cloned and characterised. A sequence identical to the common regions in In6, In7 and a novel integron from pSAL-1 was found upstream from bla CMY-11 gene at nucleotide 1-71. Eighteen nucleotides between position 71 and 72 were inserted into the bla CMY-11 gene.

Original languageEnglish
Pages (from-to)320-326
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume24
Issue number4
DOIs
StatePublished - 2004.10

Keywords

  • AmpC beta-lactamase
  • CMY-11
  • ERIC-PCR
  • Escherichia coli

Fingerprint

Dive into the research topics of 'Dissemination of Escherichia coli producing AmpC-type β-lactamase (CMY-11) in Korea'. Together they form a unique fingerprint.

Cite this